Consumer health products technologies solution provider Catalent has completed the biologics packaging expansion at its Bloomington facility in Indiana, US.

The company’s 875,000ft² facility in Bloomington specialises in sterile formulation and extensive bio-manufacturing and drug product fill/finish capacity in liquid and lyophilised vials, prefilled syringes, and cartridges.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The $14m expansion covers the addition of 15,000ft² packaging infrastructure to the biologics and sterile manufacturing site.

It also includes five new packaging suites and a new quality control laboratory.

The company’s strategic partnerships have led to the introduction of new technologies and integrated capabilities such as an Optima combination syringe assembly machine, an automated Mikron auto-injector assembly machine, and a Dividella NeoTOP x (NTX) top-load cartoner with both semi-automated and fully automated configurations.

All three high-speed lines offer quick and flexible packaging solutions to customers for vials, syringes, and devices with no glass-to-glass contact.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Biologics North America region president Mike Riley said: “The completion of this expansion marks a major milestone for our late-stage and commercial customers, allowing Catalent to focus on more complex device assembly and packaging needs for biologic products at higher volumes.

“This state-of-the-art equipment adds to our growing network of global packaging capabilities alongside our Brussels, Belgium, and Anagni, Italy drug product manufacturing sites.”

Headquartered in Somerset, New Jersey, Catalent has more than 40 facilities. In fiscal year 2019, it reported over $2.5bn in annual revenue.